It was identified that interference from fetal hemoglobin (HbF) occurs at a level lower than what is stated in the ARCHITECT Hemoglobin A1c (ln 4p52-21) package insert. The package insert indicates that the Hemoglobin A1c (HbA1c) assay is susceptible to interference effects from HbF at > 20%, while the most current data shows interference at HbF at > 5%. All in-date lots of ln 4p52-21 reagent inventory are impacted.